It was reported that ACLY was acetylated at K540, K546, and K554 by p300/CBP-associated factor (PCAF), which blocked poly-ubiquitination at these sites and stabilized ACLY under high-glucose conditions, lipid synthesis, and tumor growth [51]. This evidence concerns the gene EP300 and neoplasm.